Elbasvir–Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist TherapyGregory J. Dore, Frederick L. Altice, Alain H. Litwin et al.|Annals of Internal Medicine|2016Cited by 364
Safety, tolerability, and immunogenicity of an adult pneumococcal conjugate vaccine, V116 (STRIDE-3): a randomised, double-blind, active comparator controlled, international phase 3 trialHeather Platt, Christopher Galloway, Elizabeth A Barranco-Santana et al.|The Lancet Infectious Diseases|2024Cited by 59
Reinfection and Risk Behaviors After Treatment of Hepatitis C Virus Infection in Persons Receiving Opioid Agonist TherapyJason Grebely, Heather Platt, Gregory J. Dore et al.|Annals of Internal Medicine|2022Cited by 20